“Biomarking” the transition from genetic risk to kidney disease
- Etty Kruzel-Davila
- , Karl Skorecki
- Rambam Health Care Campus
- Technion-Israel Institute of Technology
Research output: Contribution to journal › Comment/debate
3
Scopus
citations